Last reviewed · How we verify

NCT04959747

Acupuncture for Olfactory Dysfunction in Infected COVID-19 Patients

Status unknown NA Last updated 22 July 2021
What this trial tests

NA trial testing acupuncture in Olfactory Dysfunction in 20 participants. Status unknown.

Timeline
1 August 2021
Primary endpoint
31 July 2022
30 September 2022

Quick facts

Lead sponsorHong Kong Baptist University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment20
Start date1 August 2021
Primary completion31 July 2022
Estimated completion30 September 2022
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Hong Kong Baptist University

Who can join

Adults 18 to 80, any sex, with Olfactory Dysfunction or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this a 12-week, single blinded, randomized sham controlled, and cross-over clinical trial. It will be conducted to explore the safety and efficacy of acupuncture for olfactory dysfunction in infected COVID-19 patients in Hong Kong.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE, O'Byrne L, MacKeith S, Philpott C, et al · · 2021 · cited 22× · PMID 34291812 · DOI 10.1002/14651858.cd013877.pub2
  2. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L, Webster KE, MacKeith S, Philpott C, et al · · 2022 · cited 21× · PMID 36062970 · DOI 10.1002/14651858.cd013876.pub3
  3. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L, Webster KE, MacKeith S, Philpott C, et al · · 2021 · cited 21× · PMID 34291813 · DOI 10.1002/14651858.cd013876.pub2
  4. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE, O'Byrne L, MacKeith S, Philpott C, et al · · 2022 · cited 11× · PMID 36063364 · DOI 10.1002/14651858.cd013877.pub3
  5. Acupuncture for olfactory dysfunction in infected COVID-19 patients: Study protocol for a randomized, sham-controlled clinical trial
    Zhong L, Wong Y, Leung C, Choy C, et al · · 2022
  6. Acupuncture for Olfactory Dysfunction in Infected COVID-19 Patients: Study Protocol for a Single Blind, Randomized, Sham-Controlled Clinical Trial
    Zhong LL, CHOY C, CHO H, WONG Y, et al · · 2021 · DOI 10.21203/rs.3.rs-823921/v1

Verify or expand the search:

Other trials of acupuncture

Trials testing the same drug.

Other recruiting trials for Olfactory Dysfunction

Currently open trials in the same condition.

Other Hong Kong Baptist University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04959747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing